Vaccine-Specific Recommendations by Date Published

Background

Consult the ACIP Recommendations page for a complete list of Morbidity and Mortality Weekly Reports (MMWR) on Recommendations of the Advisory Committee on Immunization Practices (ACIP) related to vaccines and immunizations.

Links to final CDC vaccination recommendations (published in MMWR) from Advisory Committee on Immunization Practices (ACIP)

Listed by Date Published

2024

• Influenza Vaccines (2024-25 Season)
  Grohskopf LA, Ferdinands JM, Blanton LH, Broder KR, Loehr J, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–25 Influenza Season.
  _{Source: MMWR. 2024 / 73(5);1–25.}

• COVID-19 Vaccines
  Panagiotakopoulos L, Godfrey M, Moulia DL, Link-Gelles R, Taylor CA, Chatham-Stephens K, et al. Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024.
  ^{Source: MMWR. 2024 / 73(16);377–381.}
• Meningococcal Vaccines
  Collins JP, Crowe SJ, Ortega-Sanchez IR, Bahta L, Campos-Outcalt D, Loehr J, et al. Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023.
  ^{Source: MMWR. 2024 / 73(15);345–350.}
• Immunization Schedule for Adults Aged 19 Years or Older
  Murthy N, Wodi AP, McNally VV, Daley MF, Cineas S. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024.
  ^{Source: MMWR. 2024 / 73(1);11–5.}
• Immunization Schedule for Children and Adolescents Aged 18 Years or Younger
  Wodi AP, Murthy N, McNally V, Daley MF, Cineas S. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024.
  ^{Source: MMWR. 2024 / 73(1);6–10.}

2023

• Polio Vaccine
  Kidd S, Clark T, Routh J, Cineas S, Bahta L, Brooks O. Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2023.
  ^{Source: MMWR. 2023 / 72(49);1327–1330.}
• Tick-Borne Encephalitis Vaccine
  Hills SL, Poehling KA, Chen WH, Staples JE. Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.
  ^{Source: MMWR. 2023 / 72(RR-5);1–29.}
• COVID-19 Vaccines
  Regan JJ, Moulia DL, Link-Gelles R, Godfrey M, Mak J, Najdowski M, et al. Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023.
  ^{Source: MMWR. 2023 / 72(42);1140–1146.}
• Respiratory Syncytial Virus Vaccine
  Fleming-Dutra KE, Jones JM, Roper LE, Prill MM, Ortega-Sanchez IR, Ortega-Sanchez DL, et al. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023.
  ^{Source: MMWR. 2023 / 72(41);1115–1122.}
• Pneumococcal Vaccine
  Farrar JL, Gierke R, Andrejko KL, Ayabina D, Zielinski L, Cohen A, et al. ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023.
  ^{Source: MMWR. 2023 / 72(39);1072.}
• COVID-19 Vaccines
  Meghani M, Salvesen Von Essen B, Zapata LB, Polen K, Galang RR, Razzaghi H, et al. COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age by Health Care Providers — Fall DocStyles Survey, United States, 2022.
  ^{Source: MMWR. 2023 / 72(39);1045–51.}
• Pneumococcal Vaccine
  Kobayashi M, Pilishvili T, Farrar JL, Leidner AJ, Gierke R, Prasad N, et al. Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.
  ^{Source: MMWR. 2023 / 72(RR-3);1–39.}
• Respiratory Syncytial Virus Prevention
  Jones JM, Fleming-Dutra KE, Prill MM, Roper LE, Brooks O, Sánchez PJ, et al. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
  ^{Source: MMWR. 2023 / 72(34);920–925.}
• Influenza Vaccines (2023-24 Season)
  Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season
  ^{Source: MMWR. 2023 / 72(RR-2);1–25.}
• Respiratory Syncytial Virus Vaccines
  Melgar M, Britton A, Roper LE, Talbot HK, Long SS, Kotton CN, et al. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
  ^{Source: MMWR. 2023 / 72(29);793–801.}
• COVID-19 Vaccines
  Moulia DL, Wallace M, Roper LE, Godfrey M, Rosenblum HG, Link-Gelles R, et al. Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
  ^{Source: MMWR. 2023;72(24);657–62.}
• Immunization Schedule for Adults Aged 19 Years or Older
  Murthy N, Wodi AP, McNally V, Cineas S, Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023.
  ^{Source: MMWR. 2023 / 72(6);141–4.}
• Immunization Schedule for Children and Adolescents Aged 18 Years or Younger
  Wodi AP, Murthy N, McNally V, Cineas S, Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023.
  ^{Source: MMWR. 2023 / 72(6);137–40.}

2022

• Measles, Mumps and Rubella Vaccine
  Krow-Lucal E, Marin M, Shepersky L, Bahta L, Loehr J, Dooling K. Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
  ^{Source: MMWR. 2022 / 71(46);1465–70.}
• COVID-19 Vaccine
  Rosenblum HG, Wallace M, Godfrey M, Roper LE, Hall E, Fleming-Dutra KE, et al. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
  ^{Source: MMWR. 2022 / 71(45);1436–41.}
• Cholera Vaccine
  Collins JP, Ryan ET, Wong KK, Daley MF, Ratner AJ, Appiah GD, et al. Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
  ^{Source: MMWR. 2022 / 71(RR-2);1–8.}
• Pneumococcal Vaccine
  Kobayashi M, Farrar JL, Gierke R, Leidner AJ, Campos-Outcalt D, Morgan RL, et al. Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
  ^{Source: MMWR. 2022 / 71(37);1174–81.}
• Influenza Vaccines (2022-23 season)
  Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
  ^{Source: MMWR. 2022;71(RR-1);1–28.}
• COVID-19 Vaccine
  Twentyman E, Wallace M, Roper LE, Anderson TC, Rubis AB, Fleming-Dutra KE, et al. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
  ^{Source: MMWR. 2022;71(31);988–92.}
• COVID-19 Vaccine
  Fleming-Dutra KE, Wallace M, Moulia DL, Twentyman E, Roper LE, Hall E, et al. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
  ^{Source: MMWR. 2022;71(26);859–68.}
• Orthopoxvirus Vaccines
  Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
  ^{Source: MMWR. 2022;71(22);734-42.}
• Rabies Vaccine
  Rao AK, Briggs D, Moore SM, Whitehill F, Campos-Outcalt D, Morgan RL, et al. Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
  ^{Source: MMWR. 2022;71(18);619–27.}
• Hepatitis B Vaccine
  Weng MK, Doshani M, Khan MA, Frey S, Ault K, Moore KL, et al. Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
  ^{Source: MMWR. 2022;71(13);477–83.}
• COVID-19 Vaccine
  Wallace M, Moulia D, Blain AE, Ricketts EK, Minhaj FS, Link-Gelles R, et al. Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022
  ^{Source: MMWR. 2022;71(11);416–21.}
• Ebola Vaccine
  Malenfant JH, Joyce A, Choi MJ, Cossaboom CM, Whitesell AN, Harcourt BH, et al. Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021
  ^{Source: MMWR. 2022;71(8);290–2.}
• Immunization Schedule for Children and Adolescents Aged 18 Years or Younger
  Wodi AP, Murthy N, Bernstein H, McNally V, Cineas S, Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022.
  ^{Source: MMWR. 2022;71(7);234–7.}
• Immunization Schedule for Adults Aged 19 Years or Older
  Murthy N, Wodi AP, Bernstein H, McNally V, Cineas S, Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022.
  ^{Source: MMWR. 2022;71(7);229–33.}
• Pneumococcal Vaccine
  Kobayashi M, Farrar JL, Gierke R, Britton A, Childs L, Leidner AJ, et al. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
  ^{Source: MMWR. 2022;71(4);109–17.}
• COVID-19 Vaccine
  Oliver SE, Wallace M, See I, Mbaeyi S, Godfrey M, Hadler SC, et al. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
  ^{Source: MMWR. 2022;71(3);90-95.}
• Zoster Vaccine
  Anderson TC, Masters NB, Guo A, Shepersky L, Leidner AJ, Lee GM, et al. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
  ^{Source: MMWR. 2022;71(3);80–4.}

2021

• Dengue Vaccine
  Paz-Bailey G, Adams L, Wong JM, Poehling KA, Chen WH, McNally V, et al. Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
  ^{Source: MMWR. 2021;70(6);1–16.}
• COVID-19 Vaccine
  Woodworth KR, Moulia D, Collins JP, Hadler SC, Jones JM, Reddy SC, et al. Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
  ^{Source: MMWR. 2021;70(45);1579–83.}
• COVID-19 Vaccine
  Mbaeyi S, Oliver SE, Collins JP, Godfrey M, Goswami ND, Hadler SC, et al. Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
  ^{Source: MMWR. 2021;70(44);1545–52.}
• COVID-19 Vaccine
  Dooling K, Gargano JW, Moulia D, Wallace M, Rosenblum HG, Blain AE, et al. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
  ^{Source: MMWR. 2021;70(38);1344–8.}
• COVID-19 Vaccine
  Rosenblum HG, Hadler SC, Moulia D, Shimabukuro TT, Su JR, Tepper NK, et al. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
  ^{Source: MMWR. 2021;70(32);1094-9.}
• Influenza Vaccines (2021-22 season)
  Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season
  ^{Source: MMWR. 2021;70(RR-5);1-28.}
• COVID-19 Vaccine
  Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
  ^{Source: MMWR. 2021;70(27);977–82.}
• COVID-19 Vaccine
  Wallace M, Woodworth KR, Gargano JW, Scobie HM, Blain AE, Moulia D, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
  ^{Source: MMWR. 2021;70(20);749-52.}
• COVID-19 Vaccine
  MacNeil JR, Su JR, Broder KR, Guh AY, Gargano JW, Wallace M, et al. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
  ^{Source: MMWR. 2021;70(17);651-6.}
• Immunization Schedule for Children and Adolescents Aged 18 Years or Younger
  Woodi AP, Ault K, Hunter P, McNally V, Szilagyi PG, Bernstein H. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2021
  ^{Source: MMWR. 2021;70(6);189–92.}
• Immunization Schedule for Adults Aged 19 Years or Older
  Freedman MS, Ault K, Bernstein H. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021
  ^{Source: MMWR. 2021;70(6);193–6.}
• COVID-19 Vaccine
  Oliver SE, Gargano JW, Scobie H, Wallace M, Hadler SC, Leung J, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
  ^{Source: MMWR. 2021;70(9);329-32.}
• Ebola Vaccine
  Choi MJ, Cossaboom CM, Whitesell AN, Dyal JW, Joyce A, Morgan RL, et al. Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
  ^{Source: MMWR. 2021;70(RR-1);1-12.}

2020

• Immunization Schedule for Children and Adolescents Aged 18 Years or Younger
  Robinson CL, Bernstein H, Poehling K, Romero J, Szilagyi P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020
  ^{Source: MMWR. 2020;69(5);130–2.}
• Immunization Schedule for Adults Aged 19 Years or Older
  Freedman MS, Hunter P, Ault K, Kroger A. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020
  ^{Source: MMWR. 2020;69(5);133–5.}
• COVID-19 Vaccine
  Dooling K, Marin M, Wallace M, McClung N, Chamberland M, Lee GM, et al. The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020
  ^{Source: MMWR. 2020;69(5152);1657-60.}
• COVID-19 Vaccine
  Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
  ^{Source: MMWR. 2020;69(5152)1653-6.}
• COVID-19 Vaccine
  Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
  ^{Source: MMWR. 2020;69(50);1922-4.}
• COVID-19 Vaccine
  Dooling K, McClung N, Chamberland M, Marin M, Wallace M, Bell B, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
  ^{Source: MMWR. 2020;69(49);1857-9}
• Meningococcal Vaccine
  Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, Stephens DS, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
  ^{Source: MMWR. 2020;69(RR-9):1–41.}
• Infuenza Vaccines (2020-21 season)
  Grohskopf LA, Alyanak E, Broder KR, Blanton LH, Fry AM, Jernigan DB, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season
  ^{Source: MMWR. 2020;69(RR-8):1–24.}
• Hepatitis A Vaccine
  Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
  ^{Source: MMWR. 2020;69(RR-5):1–38.}
• Combined DTaP-IPV-Hib-HepB Vaccine
  Oliver SE, KL Moore. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
  ^{Source: MMWR. 2020;69(RR-5):136-9.}
• Combined DTaP/Tdap/Td Vaccine
  Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
  ^{Source: MMWR. 2020;69(RR-3):77–83.}

2019

• Anthrax Vaccine
  Bower WA, Schiffer J, Atmar RL, Keitel WA, Friedlander AM, Liu L, et al. Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
  ^{Source: MMWR. 2019;68(RR-4);1–14.}
• Pneumococcal Vaccines
  Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
  ^{Source: MMWR. 2019;68(46);1069-75.}
• Influenza Vaccines (2019-20 season)
  Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season
  ^{Source: MMWR. 2019;68(RR-3);1–21.}
• Human Papillomavirus Vaccination for Adults
  Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
  ^{Source: MMWR. 2019;68(32);698-702.}
• Japanese Encephalitis Vaccine
  Hills SL, Walter EB, Atmar RL, Fischer M. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
  ^{Source: MMWR. 2019;68(RR-2);1-33.}
• Hepatitis A Vaccine
  Doshani M, Weng M, Moore KL, Romero JR, Nelson NP. Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
  ^{Source: MMWR. 2019;68(6);153-6.}
• Adult Immunization Schedule
  Kim DK, Hunter P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019
  ^{Source: MMWR. 2019;68(5)115–8.}
• Child/Adolescent Immunization Schedule
  Robinson CL, Bernstein H, Romero JR, Szilagyi P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019
  ^{Source: MMWR. 2019;68(5);112–4.}

2018

• Hepatitis A Vaccine
  Nelson NP, Link-Gelles R, Hofmeister MG, Romero JR, Moore KL, Ward JW, et al. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
  ^{Source: MMWR. 2018;67(RR-3);1-20.}
• Influenza Vaccines (2018-19 season)
  Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season
  ^{Source: MMWR. 2018;67(RR-3);1-20.}
• Quadrivalent Live Attenuated Influenza Vaccines (2018-19 season)
  Grohskopf LA, Sokolow LZ, Fry AM, Walter EB, Jernigan DB. Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
  ^{Source: MMWR. 2018:67(22);643-5.}
• Combined DTaP/Tdap/Td Vaccine
  Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  ^{Source: MMWR. 2018:67(RR-2);1-44.}
• Hepatitis B Vaccine
  Schillie S, Harris A, Link-Gelles R, Romero J, Ward J, Nelson N. Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
  ^{Source: MMWR. 2018;67(15);455-8.}
• Adult Immunization Schedule
  Kim DK, Riley LE, Hunter P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2018
  ^{Source: MMWR. 2018;67(5)158-60.}
• Child/Adolescent Immunization Schedule
  Robinson CL, Romero JR, Kempe A, Pellegrini C, Szilagyi P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2018
  ^{Source: MMWR. 2018;67(5);156-7.}
• Herpes Zoster Vaccine (Shingles)
  Dooling KL, Guo A, Patel M, Lee GM, Moore K,Belongia EA, et al. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
  ^{Source: MMWR. 2018;67(3);103-8.}
• Measles, Mumps and Rubella Vaccine
  Marin M, Marlow M, Moore KL, Patel M. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
  ^{Source: MMWR. 2018;67(1);33-8.}
• Hepatitis B Vaccine
  Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, et al. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
  ^{Source: MMWR. 2018;67(RR-1);1-33.}

2017

• Meningococcal Vaccine
  Patton ME, Stephens D, Moore K, MacNeil JR. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
  ^{Source: MMWR. 2017;66(19);509-13.}
• Oral Cholera vaccine
  Wong KK, Burdette E, Mahon BE, Mintz ED, Ryan ET, Reingold AL. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
  ^{Source: MMWR. 2017;66(18);482-5.}
• Adult Immunization Schedule
  Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017
  ^{Source: MMWR. 2017;66(5);136-8.}
• Child/Adolescent Immunization Schedule
  Robinson CL, Romero JR, Kempe A, Pellegrini C; Advisory Committee on Immunization Practices (ACIP) Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017
  ^{Source: MMWR. 2017;66(5);134-5.}

2016

• Human Papillomavirus Vaccine
  Meites E, Kempe A, Markowitz LE. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
  ^{Source: MMWR. 2016;65(49);1405-8.}
• Meningococcal Conjugate Vaccine
  MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IP, Martin SW. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016
  ^{Source: MMWR. 2016;65(43);1189-94.}
• Influenza Vaccines (2016-17 season)
  Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2016–17 Influenza Season
  ^{Source: MMWR. 2016;65(RR-5);1-54.}
• Orthopoxvirus Vaccine
  Petersen BW, Harms TJ, Reynolds MG, Harrison LH. Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
  ^{Source: MMWR. 2016;65(10);257-62.}
• Child/Adolescent Immunization Schedules
  Kim DK, Bridges CB, Harriman KH, Advisory Committee on Immunization Practices (ACIP), ACIP Adult Immunization Work Group. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016
  ^{Source: MMWR. 2016;65(4);88-90.}
• Adult Immunization Schedule
  Robinson CL, Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016
  ^{Source: MMWR. 2016;65(4);86-7.}

2015

• Meningococcal Vaccine
  MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults
  ^{Source: MMWR. 2015:64(41);1171-6.}
• Combined DTaP Polio Vaccine
  Liang J, Wallace G, Mootrey G. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose
  ^{Source: MMWR. 2015:64(34);948-9.}
• Influenza Vaccines (2015-16 season)
  Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP – U.S., 2015-16 Influenza Season
  ^{Source: MMWR. 2015:64(30);818-25.}
• Pneumococcal Vaccines
  Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the ACIP
  ^{Source: MMWR. 2015;64(34):944-7.}
• Yellow Fever Vaccine
  Staples JE, Bocchini JA, Rubin L, Fischer M. Use of Yellow Fever Vaccine Booster Doses
  Source: MMWR. 2015;64(23);647-50.
• Serogroup B Meningococcal Vaccine
  Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the ACIP, 2015
  ^{Source: MMWR. 2015;64(22);608-12.}
• Typhoid Vaccine
  Jackson BR, Iqbal S, Mahon B. Updated Recommendations for the Use of Typhoid Vaccine
  ^{Source: MMWR. 2015;64(11);305-8.}
• Human Papillomavirus Vaccine
  Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-Valent Human Papillomavirus (HPV) Vaccine
  ^{Source: MMWR. 2015;64(11);300-4.}
• Child/Adolescent Immunization Schedules
  Strikas RA, ACIP, ACIP Child/Adolescent Immunization Work Group. ACIP Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2015
  ^{Source: MMWR. 2015;64(04);93-4.}
• Adult Immunization Schedule
  Kim DK, Bridges CB, Harriman KH, ACIP, ACIP Adult Immunization Work Group. ACIP Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2015
  ^{Source: MMWR. 2015;64(04);91-2.}

2014

• Pneumococcal Vaccines
  Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al. Use of PCV-13 and PPSV-23 vaccine among adults aged 65 and older: recommendations of the ACIP
  ^{Source: MMWR. 2014;63(37);822-5.}
• Human Papillomavirus Vaccine
  Human Papillomavirus Vaccination: Recommendations of the ACIP
  ^{Source: MMWR; August 29, 2014 / 63(RR-5);1-30.}
• Influenza Vaccines (2014-15 season)
  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP – U.S., 2014-15 Influenza Season
  ^{Source: MMWR; August 15, 2014 / 63(32);691-697.}
• Meningococcal Vaccine
  Use of MenACWY-CRM Vaccine in Children Age 2 Through 23 Months at Increased Risk, Recommendations of the ACIP, 2013
  ^{Source: MMWR; June 20, 2014 / 63(24);527-30.}
• Haemophilus influenzae Type b Vaccine
  Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the ACIP, 2014
  ^{Source: MMWR; February 28, 2014 / 63(RR-1);1-14.}

2013

• Japanese Encephalitis Vaccine
  Use of Japanese Encephalitis Vaccine in Children: Recommendations of the ACIP, 2013
  ^{Source: MMWR; November 15, 2013 / 62(45);898-900.}
• Influenza Vaccines (2013-14 season)
  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP—United States, 2013–2014
  ^{Source: MMWR; September 20, 2013 / 62(RR-7);1-43.}
• Updated recommendations for use of VariZIG
  Updated Recommendations for Use of VariZIG—United States, 2013
  ^{Source: MMWR; July 19, 2013 / 62(28);574-6.}
• Pneumococcal Vaccines
  Use of PCV-13 and PPSV-23 Vaccines Among Children Aged 6–18 Years with Immunocompromising Conditions
  ^{Source: MMWR; June 28, 2013 / 62(25);521-4.}
• MMR and CRS
  Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary: Recommendations of the ACIP
  ^{Source: MMWR; June 14, 2013 / 62(RR-4);1-34.}
• Influenza interim recommendations
  Prevention and Control of Influenza with Vaccines: Interim Recommendations of ACIP, 2013
  ^{Source: MMWR; May 10, 2013 / 62(18);356-6.}
• Meningococcal disease
  Prevention and Control of Meningococcal Diseases: Recommendations of ACIP
  ^{Source: MMWR; March 22, 2013 / 62(RR-2);1-22.}
• Tdap and pregnancy
  Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women—ACIP, 2012
  ^{Source: MMWR; February 22, 2013 / 62(07);131-5.}
• Meningococcal Vaccine
  Infant Meningococcal Vaccination: ACIP Recommendations and Rationale
  ^{Source: MMWR; January 25, 2013 / 62(03);52-4.}

2012

• PCV13 and PPSV23 for adults with immunocompromising conditions
  Use of PCV13 and PPSV23 Vaccine for Adults with Immunocompromising Conditions
  ^{Source: MMWR; October 12, 2012 / 61(40);816-9.}
• Influenza vaccines (2012-13 season)
  Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP—United States, 2012–13 Influenza Season
  ^{Source: MMWR; August 17, 2012 / 61(32);613-8.}
• Tdap for adults age 65 and older
  Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older, ACIP 2012
  ^{Source: MMWR; June 28, 2012 / 61(25);468-70.}
• Licensure of PCV13 for adults age 50 and older
  Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
  ^{Source: MMWR; June 1, 2012 / 61(21);394-5.}
• New framework (GRADE) for development of evidence-based recommendations
  New Framework (GRADE) for Development of Evidence-Based Recommendations by the ACIP
  ^{Source: MMWR; May 11, 2012 / 61(18);327.}
• VariZIG for postexposure prophylaxis of varicella
  FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of Varicella
  ^{Source: MMWR; March 30, 2012 / 61(12);212.}

2011

• Hepatitis B vaccine in adults with diabetes
  Policy Note: Use of Hepatitis B Vaccine in Adults with Diabetes Mellitus
  ^{Source: MMWR; December 23, 2011 / 60(50);1709-11.}
• Use of HPV4 in males
  Policy Note: Recommendations on Use of Quadrivalent HPV in Males—ACIP, 2011
  ^{Source: MMWR; December 23, 2011 / 60(50);1705-8.}
• Health care personnel immunization
  Immunization of Health-Care Personnel: Recommendations of ACIP
  ^{Source: MMWR; November 25, 2011 / 60(RR07);1-45.}
• Herpes Zoster vaccine (Shingles)
  Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years
  ^{Source: MMWR; November 11, 2011 / 60(44);1528-8.}
• Tdap and Td vaccines and pregnancy
  Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months—ACIP, 2011
  ^{Source: MMWR; October 21, 2011 / 60(41);1424-6.}
• Intussusception and rotavirus vaccine
  Addition of History of Intussusception as a Contraindication for Rotavirus Vaccination
  ^{Source: MMWR; October 21, 2011 / 60(41);1427-7.}
• Supplemental Meningococcal
  Recommendation of the ACIP for Use of MenACWY-D Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
  ^{Source: MMWR; October 14, 2011 / 60(40);1391-2.}
• Influenza vaccines (2011-12 season)
  Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP, 2011
  ^{Source: MMWR; August 26, 2011 / 60(33);1128-32.}
• Meningococcal conjugate vaccine
  Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease—ACIP, 2011
  ^{Source: MMWR; August 5, 2011 / 60(30);1391-2.}
• Booster dose of JE vaccine
  Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine—ACIP, 2011
  ^{Source: MMWR; May 27, 2011 / 60(20);661-3.}
• JE vaccine for children
  Update on Japanese Encephalitis Vaccine for Children—United States, May 2011
  ^{Source: MMWR; May 27, 2011 / 60(20);664-5.}
• General recommendations
  General Recommendations on Immunization: Recommendations of the ACIP
  ^{Source: MMWR; January 28, 2011 / 60(RR-2);1-60.}
• Meningococcal Conjugate vaccine
  Updated Recommendations for Use of Meningococcal Conjugate Vaccines—ACIP, 2010
  ^{Source: MMWR; January 28, 2011 / 60(03);72-6.}
• Influenza (Antiviral)
  Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza: Recommendations of ACIP
  ^{Source: MMWR; January 21, 2011 / 60(RR-1);1-24.}
• Tdap vaccine
  Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Accellular Pertussis (Tdap) Vaccine from the ACIP, 2010
  ^{Source: MMWR; January 14, 2011 / 60(01);13-5.}

2010

• Pneumococcal (PCV13 and PPSV23) vaccine (infants & children)
  Prevention of Pneumococcal Disease Among Infants and Children—Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
  ^{Source: MMWR; December 10, 2010 / 59(RR-11);1-18.}
• Pneumococcal (PPSV23) vaccine (adults)
  Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using PPSV23
  ^{Source: MMWR; September 3, 2010 / 59(34);1102-6.}
• Afluria influenza vaccine (2010-2011 season)
  Update: Recommendations of ACIP Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11
  ^{Source: MMWR; August 13, 2010 /59(31);989-92.}
• Influenza (and H1N1) vaccine
  Prevention and Control of Influenza with Vaccines
  ^{Source: MMWR; August 6, 2010 /59(RR-8);1-62.}
• Yellow Fever vaccine
  Yellow Fever Vaccine: Recommendations of the ACIP
  ^{Source: MMWR; July 30, 2010 / 59(RR-7);1-27.}
• Anthrax vaccine
  Use of Anthrax Vaccine in the United States
  ^{Source: MMWR; July 23, 2010 / 59(RR-6);1-30.}
• Human Papillomavirus (HPV2 and HPV4) vaccine
  • Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the ACIP
    ^{Source: MMWR; May 28, 2010 / 59(20);626-9.}
  • Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the ACIP
    ^{Source: MMWR; May 28, 2010 / 59(20);630-2.}
• Measles, Mumps, Rubella and Varicella (MMRV) vaccine
  Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine Recommendations of the ACIP
  ^{Source: MMWR; May 7, 2010 / 59(RR-3);1-12.}
• Influenza vaccine (Fluzone high-dose)
  Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged ≥65 Years (Fluzone High-Dose) and Guidance for Use—United States, 2010
  ^{Source: MMWR; April 30, 2010 / 59(16);485-6.}
• Rabies vaccine
  Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies Recommendations of the ACIP
  ^{Source: MMWR; March 19, 2010 / 59(RR-2);1-9.}
• Meningococcal Conjugate vaccine (Menveo)
  Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use—ACIP, 2010
  ^{Source: MMWR; March 12, 2010 / 59(09);273.}
• 13-Valent Pneumococcal Conjugate vaccine (PCV13)
  Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children—ACIP, 2010
  ^{Source: MMWR; March 12, 2010 / 59(09);258-61.}
• Japanese Encephalitis vaccines
  Japanese Encephalitis Vaccines Recommendations of the ACIP
  ^{Source: MMWR; March 12, 2010 / 59(RR-1);1-27.}

2009

• Influenza A (H1N1) vaccine (2009)
  Use of Influenza A (H1N1) 2009 Monovalent Vaccine: Recommendations of the ACIP, 2009
  ^{Source: MMWR; August 28, 2009 / 58(RR-10);1-8.}
• Influenza vaccines (2009)
  Prevention and Control of Influenza: Recommendations of ACIP, 2009
  ^{Source: MMWR; July 31, 2009 / 58(RR-8);1-52.}
• Rotavirus vaccine
  Prevention of Rotavirus Gastroenteritis Among Infants and Children Recommendations of the ACIP
  ^{Source: MMWR; February 6, 2009 / 58(RR-2);1-25.}

2008

• Tdap vaccine and pregnancy
  Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants
  ^{Source: MMWR; May 30, 2008 / 57(RR-4);1-47,51.}
  • Appendix A – Summary
  • Appendix B – Abbreviations Used in This Report
• Herpes Zoster (Shingles) vaccine
  Prevention of Herpes Zoster: Recommendations of the ACIP
  ^{Source: MMWR; June 6, 2008 / 57(05);1-30.}

2007

• Varicella vaccines
  Prevention of Varicella: Recommendations of the ACIP
  ^{Source: MMWR; June 22, 2007 / 56(RR-4);1-40.}
• HPV vaccine
  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the ACIP
  ^{Source: MMWR; March 23, 2007 / 56(RR-2);1-24.}

2006

• Tdap vaccine (adults)
  Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
  ^{Source: MMWR; December 15, 2006 / 55(RR-17);1-33.}
• Hepatitis B vaccine (adults)
  A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
  ^{Source: MMWR; December 8, 2006 / 55(RR-16);1-25.}
• Rotavirus vaccine
  Prevention of Rotavirus Gastroenteritis Among Infants and Children
  ^{Source: MMWR; August 11, 2006 / 55(RR-12);1-13.}
• Hepatitis A vaccine (children)
  Prevention of Hepatitis A Through Active or Passive Immunization
  ^{Source: MMWR; May 19, 2006 / 55(RR-7);1-23.}
• Tdap vaccine (adolescents)
  Preventing Tdap Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
  ^{Source: MMWR; March 24, 2006 / 55(RR-3)1-34.}

2005

• Hepatitis B vaccine
  A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
  ^{Source: MMWR; December 23, 2005 / 54(RR-16);1-23.}

Related pages

• A New Product (VariZIG™) for Postexposure Prophylaxis of Varicella Available Under an Investigational New Drug Application Expanded Access Protocol
  ^{Source: MMWR; March 3, 2006 / 55(08);209-10.}
• Consult the American Academy of Pediatrics site for the current Status of Licensure and Recommendations for New Vaccines